| Serial Number | 99465724 |
| Word Mark | BISLYTA |
| Filing Date | Tuesday, October 28, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Tuesday, October 28, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances; pharmaceutical preparations and substances for diagnosis; pharmaceutical preparations and substances for therapy and treatment; pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; radiopharmaceuticals; radioprotectors; radiopharmaceuticals for use in theranostics; radiopharmaceutical products; radiopharmaceutical diagnostic and therapeutic preparations for medical purposes; radiopharmaceuticals for medical and clinical use; radiopharmaceutical sources and norms for nuclear medicine; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceuticals for diagnosing and treating cancer; radiopharmaceuticals, particularly for the treatment of cancer; radio therapeutic preparations; chemical substances and preparations being radioactive substances for medical purposes; radioisotopes for medical purposes; diagnostic and therapeutic radioisotopes and radiochemicals for medical purposes; radiopharmaceutical preparations and substances for endo-radionuclide therapy, brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, medical imaging and therapy; radiopharmaceutical preparations and substances for positron emission tomography; radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; theranostics in the field of oncology; theranostics in the field of precision oncology; radiopharmaceutical preparations for use in oncology, namely radiopharmaceuticals containing radioisotopes for treatment and diagnosis of tumours; target radiopharmaceuticals containing a target molecule; preparations for targeted radionuclide therapy; therapeutic agents for delivery of radioactive material; to target sites within the body; irradiated or radioactive microspheres used for therapeutic medical purposes; radiopharmaceuticals for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; radiopharmaceuticals containing radioisotopes with short half-lives for diagnostic applications; chemicals for pharmaceutical use; chemicals for radiopharmaceuticals for diagnostic uses; pharmaceutical drugs; pharmaceutical preparations for the treatment of cancer; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography, for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, for the treatment of tumour diseases; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; radioactive pharmaceutical preparations; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products; radioactive pharmaceuticals and non-radioactive reagents for producing radiopharmaceuticals for diagnosis or for therapeutic use; implantable radiotherapy devices; diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use; positron emission tomography tracers for medical use; positron emission tomography tracers prepared for ingestion or injection into humans and animals; reagents for medical purposes; preparations for use in molecular imaging (for medical use); radiotherapeutic preparations; radiodiagnostic preparations; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of disease; radioactive marked substances for diagnostic purposes; radiopharmaceuticals and radioactive marked substances for therapeutic purposes; solutions for radioactive labelling; diagnostic preparations and reagents for medical use; diagnostic substances for medical use; contrasting substances for medical imaging; scanning diagnostic reagents; diagnostic imaging agents for magnetic resonance imaging; diagnostic and therapeutic chemicals for medical purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for diagnostic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for therapeutic purposes; drug delivery agents for facilitating delivery of pharmaceutical agents for the diagnosis of cancer; drug delivery agents for facilitating delivery of pharmaceutical agents for the treatment of cancer; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals to diagnose and treat cancer; radiopharmaceutical imaging agents for selecting cancer treatments; radiopharmaceutical detection agents for selecting cancer treatments; radiopharmaceutical imaging and detection agents for selecting cancer treatments; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of diseases; pharmaceutical preparations for enhancing the efficacy of other pharmaceutical preparations in the treatment of oncological diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products preparations in the treatment of oncological diseases; tumor-seeking tracers for use in medical imaging; molecular-imaging probes for diagnostic purposes |
| Goods and Services | Radiotherapy apparatus and instruments; implantable radioactive sources of radiation; instruments and apparatus for immunotherapy and immuno-diagnostics; medical test equipment; blood analysers; diagnostic devices for medical purposes; electrodes for medical purposes; injection syringes; instrument cases for use by doctors and surgeons; special cases for medical instruments; masks for medical staff; medical apparatus and instruments, namely for the manufacture of radionuclides; pumps for medical purposes; radiological apparatus for medical purposes; special containers for medical waste; storage and transport containers for protection against ionising radiation for medical use; insulated containers for temperature sensitive products for medical use, namely, insulated containers designed for transporting and holding radiopharmaceuticals; medical containers specially designed to maintain a consistent internal temperature; temperature controlled packaging specifically adapted for the transportation of pharmaceuticals, radiopharmaceuticals, organs, blood and blood products, bio-technological (medical) and diagnostic (medical) products; temperature controlled medical containers; refrigerated medical containers for storage, transportation and cooling of medicines, pharmaceuticals, radiopharmaceuticals, organs, blood, blood products, medical supplies, medical products, bio-technological products and diagnostic products; devices for detecting ionising radiation for medical use; radiation therapy equipment; radioisotope apparatus for medical purposes; radio-oncological irradiation apparatus for medical purposes; radio-oncological irradiation instruments for medical purposes; linear accelerator for medical purposes in radiotherapy; apparatus and instruments for radioisotopic therapy; radiation therapy instruments for medical purposes; medical devices for dosimetry in the field of radiotherapy; nuclear medical tomographic scanner; diagnostic imaging apparatus for nuclear medicine; cancer irradiation apparatus for medical purposes; cancer irradiation instruments for medical purposes; apparatus for administering pharmaceuticals; apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments; applicators for pharmaceutical preparations; medical apparatus kits for preparing diagnostic imaging agents; medical apparatus for administering radiopharmaceutical diagnostic products; medical apparatus; medical instruments; medical apparatus for diagnostic radiopharmaceutical use; medical instruments for diagnostic radiopharmaceutical use; medical apparatus for diagnostic contrast agent use; medical instruments for diagnostic contrast agent use; medical apparatus for diagnostic tumor-seeking tracer use; medical instruments for diagnostic tumor-seeking tracer use; medical apparatus for diagnostic molecular-imaging probe use; medical instruments for diagnostic molecular-imaging probe use; parts and fittings for the aforesaid goods |
| Goods and Services | Provision of medical, health care and wellness (health and nutrition advice) services; provision of medical, health care and wellness (health and nutrition advice) services in relation to the prevention, treatment, prophylaxis and management of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; medical counselling services in the field of treatment, prophylaxis or prevention of medical conditions; psychedelic therapy; psychotherapy; medical treatment and therapy incorporating virtual reality; pharmaceutical advisory services; alternative medicine services; providing medical information in the field of cancer diagnosis; information, support, assistance, consultancy and advisory services in relation to the aforementioned services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 28, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 28, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 28, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Clarity Pharmaceuticals Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Eveleigh, NSW 2015 AU |
| Event Date | Event Description |
| Tuesday, October 28, 2025 | NEW APPLICATION ENTERED |
| Tuesday, October 28, 2025 | APPLICATION FILING RECEIPT MAILED |